Russian Heart Failure Journal 2013year Clinical significance of rehospitalizations in patients with CHF. Analyzing the predictive value of heart rate


To access this material please log in or register

Register Authorize
2013/№4

Clinical significance of rehospitalizations in patients with CHF. Analyzing the predictive value of heart rate

Arutyunov A.G.
State Budgetary Educational Institution of Higher Professional Education, “N.I. Pirogov Russian National Research Medical University” of the RF Ministry of Health Care, Ostrovityanova 1, Moscow 117997

Keywords: hospitalisation, prognosis, CHF, heart rate

DOI: 10.18087 / rhfj.2013.4.1862

The article presents an analysis of a new prognostic parameter, the frequency of rehospitalizations. Analysis of register data showed that any rehospitalization increases risks for death of the patient and impairs the functional condition of kidneys and myocardium. Each next hospitalization was found to increase the risk for pneumonia. The article investigates in detail the significance of heart rate and the predictive value of heart rate changes during hospitalization. A multifactor predictive model determining the risks of rehospitalization is analyzed. The model components include levels of hemoglobin and creatinine, the presence of IHD, patient’s age, heart rate, and the presence of pneumonia.
  1. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U. S., 1979 to 2004. J Am Coll Cardiol. 2008;52 (6):428–434.
  2. Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т., Данелиян М. О. Первые результаты национального эпидемиологического исследования – ЭПидемиологическое Обследование больныХ ХСН в реальной прАктике (по Обращаемости) – ЭПОХА–О–ХСН. Журнал сердечная недостаточность. 2003;3 (3):116–120.
  3. Nieminen MS, Brutsaert D, Dickstein K et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27 (22):2725–2736.
  4. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service. N Engl J Med. 2009;360 (14):1418–1128.
  5. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53 (7):557–573.
  6. Fonarow GC, Stough WG, Abraham WT et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50 (8):768–777.
  7. O’Connor CM, Miller AB, Blair JE, et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficasy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010;159 (5):841–849.
  8. Setoguchi S, Stevenson L Hospitalizations in Patients With Heart Failure: Who and Why.J Am Coll Cardiol. 2009;54 (18):1703–1705.
  9. Gheorghiade M, Mebazaa A. Introduction to acute heart failure syndromes. Am J Cardiol. 2005;96 (6A): 1G-4G.
  10. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29 (19):2388–2442.
  11. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61 (4):391–403.
  12. Felker GM, Pang PS, Adams KF et al. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010;3 (2):314–325.
  13. Gheorghiade M, Ambrosy A. Heart failure in 2010: one step forward, two steps back. Nat Rev Cardiol. 2011;8 (2):72–73.
  14. Gheorghiade M, Zannad F, Sopko G et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112 (25):3958–3968.
  15. O'Connor CM, Abraham WT, Albert NM et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008;156 (4):662–673.
  16. Rossi JS, Flaherty JD, Fonarow GC et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). Eur J Heart Fail. 2008;10 (12):1215–1223.
  17. Gheorghiade M, Abraham WT, Albert NM et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28 (8):980–988.
  18. Merrill AJ. Edema and decreased renal blood flow in patients with chronic congestive heart failure; evidence of forward failure as the primary cause of edema. J Clin Invest. 1946;25 (3):389–400.
  19. Ruggenenti P, Remuzzi G. Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney. Eur Heart J. 2011;32 (20):2476–2478.
  20. Wang NC, Maggioni AP, Konstam MA et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008;299 (22):2656–6266.
  21. Dunlay SM, Gheorghiade M, Reid KJ et al. Critical elements of cli­nical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010;12 (4):367–374.
  22. Ambrosy AP, Pang PS, Khan S et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34 (11):835–843.
  23. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119 (12 Suppl 1):S3‑S10.
  24. Gheorghiade M, Pang PS, Ambrosy AP et al. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012;17 (3):485–509.
  25. Gheorghiade M, Braunwald E. A proposed model for initial assessment and management of acute heart failure syndromes. JAMA. 2011;305 (16):1702–1703.
  26. Schrier RW, Gheorghiade M. Challenge of rehospitalizations for heart failure: potential of natriuretic doses of mineralcorticoid receptor antagonists. Am Heart J. 2011;161 (2):221–223.
Arutyunov A.G. Clinical significance of rehospitalizations in patients with CHF. Analyzing the predictive value of heart rate. Russian Heart Failure Journal. 2013;14 (4):219-227

To access this material please log in or register

Register Authorize
Ru En